AVAdam Visconti

Adam Visconti

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Adam Visconti has a total of 41 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Hepatitis C Micro‐Elimination Through Patient Navigation of Individuals Experiencing Elevated Risk in a Mid‐Atlantic Regional Healthcare System in 2022 and 2023: A Cohort Study

    by Adam Visconti, Demetrie Garner, Jessica Gabra, Stephen Fernandez

    Background and Aims: Hepatitis C virus (HCV) disproportionately impacts persons with substance use and mental health disorders. Micro‐elimination projects selectively foster diagnosis, treatment and reinfection of high priority demographic groups. A small‐scale, peer navigation focused micro‐elimination project was launched at a regional multidisciplinary and multispecialty health system in the Mid‐Atlantic to facilitate treatment engagement for high‐risk individuals. Methods: The program used electronic medical record (EMR) periodic surveillance and navigation of individuals diagnosed with HCV and either not engaged, or not completed, treatment, as well as those needing additional testing (for either sustained virologic response or high‐risk re‐testing). Specialist appointments and referrals for associated behavioral health interventions were provided. Historical propensity score matched controls were utilized to provide a comparator population. Results: Between April 2022 and July 2023, 115 persons were navigated, including 78 persons without a prior specialist appointment (New Patients), 15 persons previously engaged with a specialist but not completing treatment, and 22 patients needing additional testing. Among New Patients, 52.6% of patients attended treatment appointments, 28.2% started treatment, and 14.1% had a confirmed undetectable HCV test. Compared to historical matched controls, persons navigated were almost twice as likely to attend an appointment (HR: 1.96 [1.18–3.23], p = 0.008), and nearly three times more likely to start treatment (HR: 2.86 [1.41–5.79], p = 0.003). The median time from navigation to an appointment for New Patients was 71 days, and 143 days until starting treatment. Conclusions: A small‐scale, peer‐navigation focused micro‐navigation program successfully engaged patients but had mixed success in successfully navigating the care cascade. Despite navigation and consistent engagement, nearly half of patients dropped off at each step of the care cascade. Compared to historical controls, patients were more likely to make appointments and initiate treatment. Future efforts should be targeted at reducing times for specialist appointments and expanding treatment at diagnosis location.

  • Top Cited Papers
    Open Access

    Patient Perspectives on Artificial Intelligence in Health Care: Focus Group Study for Diagnostic Communication and Tool Implementation

    by Garrett Foresman, Joshua Biro, Alberta Tran, Kate MacRae, Sadaf Kazi, Laura Schubel, Adam Visconti, William Gallagher, Kelly M Smith, Traber Giardina, et al.

    Background: Artificial intelligence (AI) is rapidly transforming health care, offering potential benefits in diagnosis, treatment, and workflow efficiency. However, limited research explores patient perspectives on AI, especially in its role in diagnosis and communication. This study examines patient perceptions of various AI applications, focusing on the diagnostic process and communication. Objective: This study aimed to examine patient perspectives on AI use in health care, particularly in diagnostic processes and communication, identifying key concerns, expectations, and opportunities to guide the development and implementation of AI tools. Methods: This study used a qualitative focus group methodology with co-design principles to explore patient and family member perspectives on AI in clinical practice. A single 2-hour session was conducted with 17 adult participants. The session included interactive activities and breakout sessions focused on five specific AI scenarios relevant to diagnosis and communication: (1) portal messaging, (2) radiology review, (3) digital scribe, (4) virtual human, and (5) decision support. The session was audio-recorded and transcribed, with facilitator notes and demographic questionnaires collected. Data were analyzed using inductive thematic analysis by 2 independent researchers (GF and JB), with discrepancies resolved via consensus. Results: Participants reported varying comfort levels with AI applications contingent on the level of patient interaction, with digital scribe (average 4.24, range 2-5) and radiology review (average 4.00, range 2-5) being the highest, and human (average 1.68, range 1-4) being the lowest. In total, five cross-cutting themes emerged: (1) validation (concerns about model reliability), (2) usability (impact on diagnostic processes), (3) transparency (expectations for disclosing AI usage), (4) opportunities (potential for AI to improve care), and (5) privacy (concerns about data security). Participants valued the co-design session and felt they had a significant say in the discussions. Conclusions: This study highlights the importance of incorporating patient perspectives in the design and implementation of AI tools in health care. Transparency, human oversight, clear communication, and data privacy are crucial for patient trust and acceptance of AI in diagnostic processes. These findings inform strategies for individual clinicians, health care organizations, and policy makers to ensure responsible and patient-centered AI deployment in health care.


  • Open Access

    Patient Perspective on Artificial Intelligence in Healthcare: Insights for Diagnostic Communication and Tool Implementation (Preprint)

    by Garrett Foresman, Biro Joshua, Alberta Tran, Kate McRae, Sadaf Kazi, Laura Schubel, Adam Visconti, William Gallagher, Kristen Miller

    BACKGROUND Artificial intelligence (AI) Is rapidly transforming healthcare, offering potential benefits in diagnosis, treatment, and workflow efficiency. However, limited research explores patient perspectives on AI, especially in its role in diagnosis and communication. This study examines patient perceptions of various AI applications, focusing on the diagnostic process and communication. OBJECTIVE To examine patient perspectives on AI use in healthcare, particularly in diagnostic processes and communication, identifying key concerns, expectations, and opportunities to guide the development and implementation of AI tools. METHODS A co-design focus group workshop was conducted with 17 participants (patients and family members) aged 18-80. The session included interactive activities, discussions, and guideline development exploring five AI scenarios: (1) Patient Portal Messaging, (2) Radiological Imaging, (3) Ambient Digital Scribe, (4) Virtual Human Telehealth Call, (5) Clinical Decision Support for HIV Testing. Thematic analysis was used to analyze transcripts and facilitator notes RESULTS Participants reported varying comfort levels with AI applications, with higher comfort for AI tools with less direct patient interaction, such as ambient digital scribes and radiology image readers, and lower comfort for those with more direct interaction, such as virtual human telehealth calls. Five key themes regarding patient perspectives of AI emerged: (1) Concerns Around Model Development and Validation, (2) Concerns Around AI Systems for Patients and Providers, (3) Expectations Around Disclosure of AI Usage, (4) Excitement and Opportunities for AI to Better Address Patient Needs, (5) Patient Concerns Around Data Protection, Privacy, and Security. Participants emphasized the importance of transparency in AI development validation, preferred AI as a supplementary tool rather than a replacement for human clinicians and stressed the need for clear communication about AI’s role in their care. They also highlighted the potential for AI to enhance patient understanding and engagement while expressing concerns about data security and privacy. CONCLUSIONS This study highlights the importance of incorporating patient perspectives in the design and implementation of AI tools in healthcare. Transparency, human oversight, clear communication, and data privacy are crucial for patient trust and acceptance of AI in diagnostic processes. These findings inform strategies for individual clinicians, healthcare organizations, and policymakers to ensure responsible and patient-centered AI deployment in healthcare.

  • Open Access

    Intention to Initiate HIV Pre-exposure Prophylaxis Among Cisgender Women in a High HIV Prevalence U.S. City

    by Rachel K. Scott, Shawnika J. Hull, Jim C. Huang, Peggy P. Ye, Pamela Lotke, Jason Beverley, Patricia Moriarty, Dhikshitha Balaji, Allison Ward, Jennifer Holiday, et al.


  • Migraine care practices in primary care: results from a national US survey

    by Elisabeth Callen, Tarin Clay, Jillian Alai, Paul Crawford, Adam Visconti, Andrea Nederveld, Inez Cruz, Bailey Perez, Karen L Roper, Tamara K Oser, et al.

    Background: Primary care clinicians play a critical role in diagnosis and treatment of migraine, yet barriers exist. This national survey assessed barriers to diagnosis and treatment of migraine, preferred approaches to receiving migraine education, and familiarity with recent therapeutic innovations. Methods: The survey was created by the American Academy of Family Physicians (AAFP) and Eli Lilly and Company and distributed to a national sample through the AAFP National Research Network and affiliated PBRNs from mid-April through the end of May 2021. Initial analyses were descriptive statistics, ANOVAs, and Chi-Square tests. Individual and multivariate models were completed for: adult patients seen in a week; respondent years since residency; and adult patients with migraine seen in a week. Results: Respondents who saw fewer patients were more likely to indicate unclear patient histories were a barrier to diagnosing. Respondents who saw more patients with migraine were more likely to indicate the priority of other comorbidities and insufficient time were barriers to diagnosing. Respondents who had been out of residency longer were more likely to change a treatment plan due to attack impact, quality of life, and medication cost. Respondents who had been out of residency shorter were more likely to prefer to learn from migraine/headache research scientists and use paper headache diaries. Conclusions: Results demonstrate differences in familiarity with migraine diagnosis and treatment options based on patients seen and years since residency. To maximise appropriate diagnosis within primary care, targeted efforts to increase familiarity and decrease barriers to migraine care should be implemented.